| Institution: | 1. University of Torino, Department of Medical Sciences, Torino, Italy;2. Communicated by Mario Tosi;3. Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania;4. Department of Biomedical Informatics, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania;5. Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania;6. Department of Pathology, University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania;7. S.C.D.U. Medical Genetics, Az. Osp. Città della Salute e della Scienza, Torino, Italy;8. Department of Neuroscience, Az. Osp. Città della Salute e della Scienza, Torino, Italy;9. Department of Neurology, Ophthalmology and Genetics, di Bologna, Department of Biomedical and NeuroMotor Sciences (DIBINEM) Alma Mater Studiorum, Bologna, Italy;10. NIH Undiagnosed Diseases Program, NIH Office of Rare Disease, Research and NHGRI, Bethesda, Maryland;11. CHU de Clermont‐Ferrand, Department of Genetics and Cytogenetics, France;12. Neurologie, Hopital Caremeau, Centre Hospitalo‐Universitaire de Nimes, Nimes, France;13. University of Bologna, IRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Biomedical and NeuroMotor Sciences (DIBINEM), Alma Mater Studiorum, Italy;14. Hospital de Clínicas de Porto Alegre & Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil;15. Nemours Biomedical Research, Alfred I. duPont Hospital for Children, Wilmington, Delaware;16. Department of Medical Genetics, Clinics Hospital of Ribeirao Preto, University of Sao Paulo, Sao Paulo, Brazil;17. Institut National de la Santé et de la Recherche Médicale (INSERM) – Paris Diderot Sorbonne Paris Cité University, 18. Robert Debré Hospital, Paris, France;19. Assistance Publique des Hopitaux de Paris, Reference Center for Rare Diseases “Leukodystrophies”, Child Neurology and Metabolic Disorders Department, Paris, France;20. Department of Neuroscience, Neurology, Uppsala University, Uppsala, Sweden;21. Parkinson's disease and Movement Disorders Clinic, Department of Neurology, Chaim Sheba Medical Center, Tel Aviv, Israel;22. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel;23. Department of Neurology, University of Heidelberg, Heidelberg, Germany;24. Dept. of Neurology, Klinikum Ludwigshafen, Ludwigshafen, Germany;25. Dept. of Neurology, Friedrich‐Baur‐Institute, Ludwig‐Maximilians‐University, Munich, Germany;26. German Center for Vertigo and Balance Disorders, Munich, Germany;27. DZNE – German Center for Neurodegenerative Diseases, Munich, Germany;28. German Network for Mitochondrial Disorders, (mitoNET), Germany;29. Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, California;30. Montreal Neurological Institute, McGill University, Montreal, Canada;31. Department of Neurological Sciences, CHA – H?pital de l'Enfant‐Jésus, Quebec City, Canada;32. Department of Neurology, Childrens National Medical Center, Washington, District of Columbia;33. Dept. of Immunology, Genetics and Pathology, Section of Clinical Genetics, The Rudbeck laboratory, Uppsala University Children's Hospital, Uppsala, Sweden;34. University of Delaware, Department of Biology, Newark, Delaware;35. Thomas Jefferson University, Jefferson Medical College, Philadelphia, Pennsylvania |
